Quick Takeaways
- Anthony P. Adamis has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $61,783.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Anthony P. Adamis
- Location
- New York, NY
- Summary
- The estimated net worth of Anthony P. Adamis is at least $61,783 dollars as of 11 Apr 2025. Anthony P. Adamis is the Director of EyePoint Pharmaceuticals, Inc. and owns shares of EyePoint, Inc. (EYPT) stock worth about $61.8K.
- Signature
- /s/ Andrew Oxtoby, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Anthony P. Adamis and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: EyePoint Pharmaceuticals, Inc. ($61,783).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Anthony P. Adamis
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| EYPT | EyePoint Pharmaceuticals, Inc. | Director | $61,783 | 23 Jun 2024 | ||
| KLRS | Kalaris Therapeutics, Inc. | Director | 10 Apr 2025 |
Insider Transactions Reported by Anthony P. Adamis:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.